Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase
- 20 January 2004
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 18 (3) , 589-591
- https://doi.org/10.1096/fj.03-0983fje
Abstract
SPECIFIC AIMSThis study determined the neuroprotective effect of dextromethorphan (DM) in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease (PD). Using wild-type and gene knockout mice, the role of oxygen free radical producing NADPH oxidase in the DM-afforded neuroprotection was examined.PRINCIPAL FINDINGS1. DM protects substantia nigra pars compacta (SNpc) dopaminergic neurons against MPTP-induced degenerationWe used a subchronic dosing regiment of MPTP injections to induce lesions in the nigrostriatal dopaminergic pathway. C57BL/6J mice received daily subcutaneous (s.c.) injections of vehicle or MPTP (15 mg free base/kg body weight) for 6 consecutive days. Six or 21 days later, the mice were killed. We quantified the MPTP-induced loss of SNpc tyrosine hydroxylase-immunoreactive (TH-ir) neurons and the decrease in striatal catecholamine content. To determine the effect of DM on the MPTP-induced dopaminergic neuronal lesions, mice were given twice-daily s.c. injec...Keywords
This publication has 44 references indexed in Scilit:
- Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's diseaseThe FASEB Journal, 2003
- Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson DiseaseJournal of Neuroscience, 2002
- Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's diseaseProceedings of the National Academy of Sciences, 2001
- Induction of gp91-phox, a Component of the Phagocyte NADPH Oxidase, in Microglial Cells during Central Nervous System InflammationJournal of Cerebral Blood Flow & Metabolism, 2001
- Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson diseaseNature Medicine, 1999
- Mitochondrial dysfunction in Parkinson's diseaseBiochemical Society Symposia, 1999
- ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASEAnnual Review of Neuroscience, 1999
- NADPH Oxidase: An UpdateBlood, 1999
- NORMAL MPTP BINDING IN PARKINSONIAN SUBSTANTIA NIGRA: EVIDENCE FOR EXTRANEURONAL TOXIN CONVERSION IN HUMAN BRAINThe Lancet, 1985
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983